SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

VERTEX PHARMACEUTICALS INC / MA (VRTX)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
3.5 / 10
Letters
2
Latest Activity
May. 7, 2025
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
May. 7, 2025 UPLOAD Neutral/Informational Low The SEC has completed its review of Vertex Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2024. They remind the company and its management that they are respons… Read Filing EDGAR
May. 5, 2025 CORRESP Concern from SEC Moderate Vertex Pharmaceuticals, Inc. has responded to comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the royalt… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.